Author:
Gaziev D,Galimberti M,Polchi P,Angelucci E,Giardini C,Baronciani D,Andreani M,Persini B,Erer B,Sodani P,Manna M,Nicolini G,Visani G,Lucarelli G
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference42 articles.
1. Kantarjian H, Melo J, Tura S et al. Chronic myelogenous leukemia: disease biology and current and future therapeutic strategies. In Schechter GP, Berliner N, Telen MJ (eds). Hematology 2000 Education Program Book American Society of Hematology: San Francisco, CA, USA 2000 p 90
2. Druker BJ, Talpaz M, Resta DJ et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia New Engl J Med 2001 344: 1031 1037
3. The Italian Cooperative Study Group on Chronic Myeloid Leukemia. Long-term follow-up of the Italian trial of interferon-a versus conventional chemotherapy in chronic myeloid leukemia Blood 1998 92: 1541 1548
4. Kantarjian HM, Smith TL, O'Brein S et al. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-a therapy Ann Intern Med 1995 122: 254 261
5. Chronic Myeloid Leukemia Trials’ Collaborative Group. Interferon alpha versus chemotherapy for chronic myeloid leukemia: a meta-analysis of seven randomized trials J Natl Cancer Inst 1997 89: 1616 1620
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献